Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,977 | 437 | 96.4% |
| Education | $257.10 | 5 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $955.25 | 55 | $0 (2024) |
| ABBVIE INC. | $764.88 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $588.06 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $559.41 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $551.89 | 23 | $0 (2024) |
| PFIZER INC. | $488.90 | 41 | $0 (2024) |
| Astellas Pharma US Inc | $466.32 | 16 | $0 (2024) |
| Abbott Laboratories | $316.25 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $296.19 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $279.98 | 23 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,891 | 106 | ABBVIE INC. ($433.22) |
| 2023 | $851.23 | 44 | AbbVie Inc. ($299.35) |
| 2022 | $70.44 | 4 | Novo Nordisk Inc ($39.05) |
| 2021 | $18.81 | 1 | AbbVie Inc. ($18.81) |
| 2020 | $206.67 | 12 | Novo Nordisk Inc ($84.15) |
| 2019 | $1,369 | 89 | Novo Nordisk Inc ($178.94) |
| 2018 | $1,325 | 79 | Medtronic USA, Inc. ($206.74) |
| 2017 | $1,503 | 107 | Merck Sharp & Dohme Corporation ($263.75) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PAIN | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: PAIN | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.69 | General |
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Obesity | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: PAIN | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Biological | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 463 | 620 | $87,998 | $22,822 |
| 2022 | 6 | 467 | 611 | $82,123 | $27,182 |
| 2021 | 6 | 432 | 586 | $72,100 | $45,503 |
| 2020 | 8 | 446 | 634 | $85,334 | $40,730 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 331 | $35,606 | $11,666 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $40,633 | $7,146 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 59 | $8,773 | $2,544 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 36 | $2,491 | $1,385 | 55.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 15 | $495.00 | $80.99 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 326 | $32,222 | $12,580 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 171 | 171 | $38,817 | $9,337 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 43 | $5,891 | $2,474 | 42.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,210 | $1,441 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 33 | $2,158 | $1,206 | 55.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 24 | 25 | $825.00 | $143.74 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 197 | 334 | $32,737 | $22,926 | 70.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 128 | 128 | $29,056 | $16,868 | 58.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 24 | $3,288 | $2,561 | 77.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 45 | $2,835 | $2,009 | 70.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 23 | $3,128 | $973.98 | 31.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 31 | 32 | $1,056 | $166.25 | 15.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 195 | 370 | $37,246 | $18,466 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 129 | 129 | $29,283 | $14,678 | 50.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 24 | 24 | $8,064 | $4,087 | 50.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 40 | $4,826 | $1,464 | 30.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 18 | $3,067 | $894.13 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 22 | $1,465 | $840.60 | 57.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 13 | $789.30 | $211.59 | 26.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 18 | 18 | $594.00 | $88.62 | 14.9% |
About Dr. Matthew Cunningham, MD
Dr. Matthew Cunningham, MD is a Family Medicine healthcare provider based in Clifton Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114988904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Cunningham, MD has received a total of $7,234 in payments from pharmaceutical and medical device companies, with $1,891 received in 2024. These payments were reported across 442 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,977).
As a Medicare-enrolled provider, Cunningham has provided services to 1,808 Medicare beneficiaries, totaling 2,451 services with total Medicare billing of $136,237. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clifton Park, NY
- Active Since 03/31/2006
- Last Updated 05/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114988904
Products in Payments
- VRAYLAR (Drug) $464.76
- Ozempic (Drug) $418.72
- JANUVIA (Drug) $395.19
- FARXIGA (Drug) $335.65
- CHANTIX (Drug) $249.57
- XARELTO (Drug) $229.50
- O-ARM-ST (Device) $206.74
- Wegovy (Drug) $204.38
- JARDIANCE (Drug) $200.82
- FREESTYLE LIBRE 3 (Device) $179.74
- UBRELVY (Drug) $175.64
- ENTRESTO (Drug) $162.70
- MOUNJARO (Drug) $150.84
- NURTEC ODT (Drug) $148.88
- TRADJENTA (Drug) $144.11
- QULIPTA (Drug) $138.07
- STIOLTO (Drug) $136.02
- BREO (Drug) $131.63
- Saxenda (Drug) $127.39
- SOLIQUA (Drug) $121.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clifton Park
Renata Mazzei -Klokiw, Md, MD
Family Medicine — Payments: $12,447
Antonio Gregorian, Md, MD
Family Medicine — Payments: $10,175
Renee Argubano, Md, MD
Family Medicine — Payments: $8,942
Steven Balsamo, Do, DO
Family Medicine — Payments: $8,162
Dr. Steffani Cotugno, D.o, D.O
Family Medicine — Payments: $7,025
Neema Afejuku-Adelaja, M.d, M.D
Family Medicine — Payments: $5,534